Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Data Warehousing | 2 | 2017 | 116 | 0.76 | Why? |
| Electronic Health Records | 5 | 2019 | 3492 | 0.73 | Why? |
| Database Management Systems | 1 | 2017 | 32 | 0.68 | Why? |
| Hospital Information Systems | 1 | 2017 | 115 | 0.60 | Why? |
| Medical History Taking | 1 | 2017 | 350 | 0.58 | Why? |
| Celiac Disease | 2 | 2018 | 471 | 0.55 | Why? |
| Health Services Research | 1 | 2017 | 756 | 0.42 | Why? |
| Paris | 4 | 2021 | 1287 | 0.36 | Why? |
| Data Mining | 3 | 2019 | 767 | 0.34 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.30 | Why? |
| Quality of Health Care | 1 | 2017 | 1948 | 0.29 | Why? |
| Hospitals, University | 2 | 2017 | 4173 | 0.29 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.26 | Why? |
| Breast Neoplasms | 2 | 2017 | 3633 | 0.24 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.21 | Why? |
| Haloperidol | 1 | 2021 | 78 | 0.21 | Why? |
| Chlorpromazine | 1 | 2021 | 130 | 0.20 | Why? |
| Enteropathy-Associated T-Cell Lymphoma | 1 | 2018 | 2 | 0.20 | Why? |
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2018 | 21 | 0.20 | Why? |
| Renal Tubular Transport, Inborn Errors | 1 | 2018 | 6 | 0.19 | Why? |
| Hypercalciuria | 1 | 2018 | 8 | 0.19 | Why? |
| Nephrocalcinosis | 1 | 2018 | 14 | 0.19 | Why? |
| Administrative Claims, Healthcare | 1 | 2019 | 124 | 0.19 | Why? |
| Kidney | 3 | 2018 | 3648 | 0.19 | Why? |
| Sodium Chloride Symporter Inhibitors | 1 | 2018 | 45 | 0.18 | Why? |
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2018 | 49 | 0.18 | Why? |
| Renal Artery Obstruction | 1 | 2018 | 27 | 0.18 | Why? |
| Apolipoproteins | 1 | 2017 | 33 | 0.17 | Why? |
| Systems Integration | 1 | 2017 | 72 | 0.17 | Why? |
| Renal Artery | 1 | 2018 | 66 | 0.17 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.16 | Why? |
| Multiple Trauma | 1 | 2017 | 80 | 0.16 | Why? |
| Heterozygote | 1 | 2017 | 249 | 0.16 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.16 | Why? |
| Albuminuria | 1 | 2017 | 164 | 0.16 | Why? |
| Mineralocorticoid Receptor Antagonists | 1 | 2018 | 203 | 0.16 | Why? |
| Peritoneal Neoplasms | 1 | 2017 | 110 | 0.16 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.16 | Why? |
| International Classification of Diseases | 1 | 2019 | 265 | 0.15 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.15 | Why? |
| Infarction | 1 | 2018 | 206 | 0.15 | Why? |
| Magnesium | 1 | 2018 | 290 | 0.15 | Why? |
| Osteomyelitis | 1 | 2017 | 131 | 0.15 | Why? |
| Hospitalization | 7 | 2021 | 54280 | 0.14 | Why? |
| Calcium Channel Blockers | 1 | 2018 | 367 | 0.14 | Why? |
| Adrenergic beta-Antagonists | 1 | 2018 | 465 | 0.14 | Why? |
| Glomerular Filtration Rate | 2 | 2017 | 1262 | 0.13 | Why? |
| Iron-Binding Proteins | 1 | 2013 | 10 | 0.13 | Why? |
| Friedreich Ataxia | 1 | 2013 | 6 | 0.13 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.13 | Why? |
| Hyponatremia | 1 | 2017 | 371 | 0.13 | Why? |
| Data Accuracy | 1 | 2019 | 715 | 0.13 | Why? |
| Aneurysm, Dissecting | 1 | 2018 | 303 | 0.12 | Why? |
| Pseudomonas Infections | 1 | 2017 | 425 | 0.12 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.12 | Why? |
| Antipsychotic Agents | 1 | 2021 | 887 | 0.12 | Why? |
| France | 5 | 2020 | 12074 | 0.12 | Why? |
| 3' Untranslated Regions | 1 | 2013 | 318 | 0.11 | Why? |
| Hospitals, Urban | 1 | 2017 | 950 | 0.11 | Why? |
| Depressive Disorder, Major | 1 | 2021 | 852 | 0.11 | Why? |
| Information Storage and Retrieval | 1 | 2017 | 644 | 0.11 | Why? |
| Genetic Variation | 2 | 2017 | 3919 | 0.11 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.11 | Why? |
| Intestinal Mucosa | 1 | 2018 | 1046 | 0.11 | Why? |
| Anemia, Sickle Cell | 1 | 2017 | 546 | 0.10 | Why? |
| Bariatric Surgery | 1 | 2021 | 1298 | 0.10 | Why? |
| Obesity, Morbid | 1 | 2021 | 1340 | 0.10 | Why? |
| Hospital Mortality | 3 | 2020 | 22087 | 0.10 | Why? |
| Obesity | 2 | 2021 | 7388 | 0.10 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.10 | Why? |
| Switzerland | 1 | 2017 | 2738 | 0.10 | Why? |
| Heart Defects, Congenital | 1 | 2019 | 933 | 0.10 | Why? |
| Killer Cells, Natural | 1 | 2018 | 2093 | 0.09 | Why? |
| Vascular Surgical Procedures | 1 | 2017 | 882 | 0.09 | Why? |
| Workflow | 1 | 2017 | 2373 | 0.09 | Why? |
| Female | 17 | 2021 | 380317 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.08 | Why? |
| Liver | 1 | 2021 | 4007 | 0.08 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.08 | Why? |
| Aged | 13 | 2021 | 215776 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2017 | 1956 | 0.07 | Why? |
| Thromboembolism | 1 | 2018 | 2101 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2017 | 1931 | 0.06 | Why? |
| Humans | 23 | 2021 | 930598 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.06 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2018 | 3892 | 0.06 | Why? |
| Liver Diseases | 1 | 2017 | 2698 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.06 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.05 | Why? |
| Prevalence | 3 | 2019 | 25773 | 0.05 | Why? |
| Adult | 11 | 2021 | 244371 | 0.05 | Why? |
| Receptors, sigma | 1 | 2021 | 167 | 0.05 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.05 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.05 | Why? |
| Gene Expression Regulation | 1 | 2013 | 4020 | 0.05 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 5277 | 0.05 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.05 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.05 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.05 | Why? |
| MicroRNAs | 1 | 2013 | 1787 | 0.05 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Fibromuscular Dysplasia | 1 | 2018 | 9 | 0.05 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.05 | Why? |
| Glutathione S-Transferase pi | 1 | 2017 | 10 | 0.04 | Why? |
| Renal Circulation | 1 | 2018 | 44 | 0.04 | Why? |
| Glutathione Transferase | 1 | 2017 | 86 | 0.04 | Why? |
| Body Mass Index | 2 | 2021 | 4306 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.04 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.04 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.04 | Why? |
| Triple Negative Breast Neoplasms | 1 | 2017 | 92 | 0.04 | Why? |
| Heme Oxygenase-1 | 1 | 2017 | 90 | 0.04 | Why? |
| Diuretics | 1 | 2018 | 326 | 0.04 | Why? |
| Hypernatremia | 1 | 2017 | 182 | 0.04 | Why? |
| Debridement | 1 | 2017 | 172 | 0.04 | Why? |
| Apolipoprotein L1 | 1 | 2017 | 161 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Intestine, Small | 1 | 2018 | 336 | 0.04 | Why? |
| Antidepressive Agents | 1 | 2021 | 509 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.04 | Why? |
| Chemokines | 1 | 2021 | 1095 | 0.04 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.03 | Why? |
| Chemotherapy, Adjuvant | 1 | 2017 | 606 | 0.03 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Hematoma | 1 | 2018 | 305 | 0.03 | Why? |
| Neoadjuvant Therapy | 1 | 2017 | 554 | 0.03 | Why? |
| Trinucleotide Repeat Expansion | 1 | 2013 | 9 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Terminology as Topic | 1 | 2019 | 546 | 0.03 | Why? |
| Proton Pump Inhibitors | 1 | 2018 | 377 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| Gene Order | 1 | 2013 | 144 | 0.03 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.03 | Why? |
| Reference Standards | 1 | 2017 | 1163 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.03 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Atherosclerosis | 1 | 2018 | 768 | 0.02 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Haplotypes | 1 | 2013 | 853 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Gene Frequency | 1 | 2013 | 1210 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.02 | Why? |
| Kidney Diseases | 1 | 2018 | 1434 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.02 | Why? |
| Base Sequence | 1 | 2013 | 3581 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| African Americans | 1 | 2017 | 3363 | 0.01 | Why? |
| Patient Admission | 1 | 2019 | 5250 | 0.01 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.01 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2013 | 3607 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2013 | 4027 | 0.01 | Why? |
| Computational Biology | 1 | 2013 | 4514 | 0.01 | Why? |
| Cell Line | 1 | 2013 | 12040 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Case-Control Studies | 1 | 2013 | 17671 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Pandemics | 1 | 2021 | 389249 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
Jannot's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(163)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_